FDA, Compounder Reach Temporary Agreement, Firm Gets Wish For New Inspection

503B compounder Cantrell Drug Company and FDA have reached a temporary agreement to reinspect the facility after FDA moved to force the company to shut down and the compounder filed a subsequent restraining order against the government, according to a new document filed in the case on Friday (March 9). As Inside Health Policy reported, FDA and the Department of Justice filed a request for a preliminary injunction in the U.S. District Court for the Eastern District of Arkansas...